[1]
Tholander , B., Koliadi , A., Botling , J., Dahlstrand , H., Von Heideman , A., Ahlström , H., Öberg , K. and Ullenhag , G.J. 2020. Complete response with combined BRAF and MEK inhibition in BRAF mutated advanced low-grade serous ovarian carcinoma. Upsala Journal of Medical Sciences. 125, 4 (Oct. 2020), 325–329. DOI:https://doi.org/10.1080/03009734.2020.1826612.